Literature DB >> 8062273

Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms.

D Fabbro1, C Di Loreto, C A Beltrami, A Belfiore, R Di Lauro, G Damante.   

Abstract

TTF-1 and PAX-8 are tissue-specific transcription factors expressed in the thyroid follicular cells, contributing to the maintenance of the differentiated phenotype. In fact, it has been demonstrated that TTF-1 and PAX-8 are able to activate transcription from thyroglobulin and thyroperoxidase (TPO) promoters, the transcriptional activity of which is in vivo restricted only to the thyroid follicular cell. In order to gain insight into how these transcription factors control in vivo the differentiation of the thyroid cell and to have a better molecular characterization of human thyroid tumors, TTF-1, PAX-8, thyroglobulin, and TPO mRNA levels were measured in nonmalignant and malignant human thyroid tissues. Results indicate that the expression of TTF-1 and PAX-8 is not sufficient per se for the expression of the thyroid-differentiated phenotype. Furthermore, in follicular adenomas, PAX-8 mRNA levels are strictly related to TPO mRNA levels, suggesting that the amount of PAX-8 could play a role in the modulation of TPO gene expression. TTF-1 mRNA is always well detectable in papillary carcinomas and, in contrast, always absent in anaplastic carcinomas. Identical results were obtained when the expression of TTF-1 protein was investigated using immunohistochemistry. Thus, TTF-1 gene expression could be a molecular marker in order to distinguish these two types of thyroid neoplasms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062273

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

1.  Expression and function of the homeodomain-containing protein Hex in thyroid cells.

Authors:  L Pellizzari; A D'Elia; A Rustighi; G Manfioletti; G Tell; G Damante
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

2.  Thyroid-specific transcription factors control Hex promoter activity.

Authors:  Cinzia Puppin; Angela V D'Elia; Lucia Pellizzari; Diego Russo; Franco Arturi; Ivan Presta; Sebastiano Filetti; Clifford W Bogue; Lee A Denson; Giuseppe Damante
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

Review 3.  Cervical lymph node metastases from remote primary tumor sites.

Authors:  Fernando López; Juan P Rodrigo; Carl E Silver; Missak Haigentz; Justin A Bishop; Primož Strojan; Dana M Hartl; Patrick J Bradley; William M Mendenhall; Carlos Suárez; Robert P Takes; Marc Hamoir; K Thomas Robbins; Ashok R Shaha; Jochen A Werner; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2015-12-29       Impact factor: 3.147

4.  Transcriptional control of PAX4-regulated miR-144/451 modulates metastasis by suppressing ADAMs expression.

Authors:  J Zhang; X Qin; Q Sun; H Guo; X Wu; F Xie; Q Xu; M Yan; J Liu; Z Han; W Chen
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

5.  Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?

Authors:  Lizhe Ai; Yaqin Yu; Xiaoli Liu; Chong Wang; Jieping Shi; Hui Sun; Qiong Yu
Journal:  Front Med       Date:  2014-01-23       Impact factor: 4.592

6.  Associations between rs965513/rs944289 and papillary thyroid carcinoma risk: a meta-analysis.

Authors:  Lizhe Ai; Xiaoli Liu; Yuhang Yao; Yaqin Yu; Hui Sun; Qiong Yu
Journal:  Endocrine       Date:  2014-04-11       Impact factor: 3.633

7.  Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.

Authors:  Hideo Watanabe; Joshua M Francis; Michele S Woo; Banafsheh Etemad; Wenchu Lin; Daniel F Fries; Shouyong Peng; Eric L Snyder; Purushothama Rao Tata; Francesca Izzo; Anna C Schinzel; Jeonghee Cho; Peter S Hammerman; Roel G Verhaak; William C Hahn; Jayaraj Rajagopal; Tyler Jacks; Matthew Meyerson
Journal:  Genes Dev       Date:  2013-01-15       Impact factor: 11.361

8.  A novel orthotopic mouse model of human anaplastic thyroid carcinoma.

Authors:  Carmelo Nucera; Matthew A Nehs; Michal Mekel; Xuefeng Zhang; Richard Hodin; Jack Lawler; Vânia Nose; Sareh Parangi
Journal:  Thyroid       Date:  2009-10       Impact factor: 6.568

9.  Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology.

Authors:  Lester J Layfield; Sinchita Roy-Chowdhuri; Zubair Baloch; Hormoz Ehya; Kim Geisinger; Susan J Hsiao; Oscar Lin; Neal I Lindeman; Michael Roh; Fernando Schmitt; Nikoletta Sidiropoulos; Paul A VanderLaan
Journal:  Diagn Cytopathol       Date:  2016-08-26       Impact factor: 1.582

Review 10.  Immunotherapy for advanced thyroid cancers - rationale, current advances and future strategies.

Authors:  Jena D French
Journal:  Nat Rev Endocrinol       Date:  2020-08-24       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.